Wound Fluid Cytokine Profile Following Bone Regeneration Procedures.


Journal

The Journal of oral implantology
ISSN: 0160-6972
Titre abrégé: J Oral Implantol
Pays: United States
ID NLM: 7801086

Informations de publication

Date de publication:
01 Apr 2020
Historique:
pubmed: 8 1 2020
medline: 6 5 2020
entrez: 8 1 2020
Statut: ppublish

Résumé

Clinical parameters available to evaluate early healing phases of bone regeneration procedures are limited. This study explores wound fluid (WF) content for molecular markers to differentiate wound healing responses in the early postoperative period after bone graft placement. Fifteen patients (50 ± 5 years old; 8 men) scheduled to receive tooth extraction and bone graft placement at maxillary nonmolar single-tooth sites were recruited. Primary wound closure was not intended at time of surgery. Gingival crevicular fluid from adjacent teeth or WF from surgical wound edges were collected (30 seconds) at baseline, at 3, 6, and 9 days, and at 1 and 4 months. Multiplex protein assay was used to determine concentration of various wound healing mediators. Immediately after surgery, 87% of surgical sites exhibited open wound. At day 9, mean wound exposure was 4.8 ± 0.4 mm. At 1 month, all wounds were clinically closed. The WF tripled in volume at day 3 and day 6 (P ≤ .05), compared with baseline gingival crevicular fluid, and gradually decreased as wounds closed. The WF concentrations of interleukin (IL)-6, placental growth factor, plasminogen activator inhibitor 1, insulin-like growth factor binding protein 1, and soluble cluster determinant 40 ligand were increased during early healing days, generally with peak concentration at day 6 (P ≤ .004). Conversely, WF concentrations of IL-18 and epidermal growth factor were decreased after surgery, generally not reaching baseline values until wound closure (P ≤ .008). In general, WF cytokine expression kinetics were concordant with wound closure dynamics (P ≤ .04). These results suggest that WF molecular markers such as IL-6, and to a lesser extent placental growth factor and IL-18, might help differentiate wound healing responses after bone regeneration procedures.

Identifiants

pubmed: 31909694
pii: 425879
doi: 10.1563/aaid-joi-D-19-00061
doi:

Substances chimiques

Cytokines 0
Placenta Growth Factor 144589-93-5

Types de publication

Journal Article

Langues

eng

Pagination

107-113

Auteurs

Binnaz Leblebicioglu (B)

Division of Periodontology, College of Dentistry, The Ohio State University, Columbus, Ohio.

Lamees Alssum (L)

Department of Periodontics & Community Dentistry, College of Dentistry, King Saud University, Saudi Arabia; previously with The Ohio State University, Columbus, Ohio.

Timothy D Eubank (TD)

Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Mogantown, WV.

Vedat O Yildiz (VO)

Center for Biostatistics, College of Medicine, The Ohio State University, Columbus, Ohio.

Dimitris N Tatakis (DN)

Division of Periodontology, College of Dentistry, The Ohio State University, Columbus, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH